170 related articles for article (PubMed ID: 38637838)
1. BCOR::CREBBP fusion in malignant neuroepithelial tumor of CNS expands the spectrum of methylation class CNS tumor with BCOR/BCOR(L1)-fusion.
Ebrahimi A; Waha A; Schittenhelm J; Gohla G; Schuhmann MU; Pietsch T
Acta Neuropathol Commun; 2024 Apr; 12(1):60. PubMed ID: 38637838
[TBL] [Abstract][Full Text] [Related]
2. CNS tumor with CREBBP::BCORL1 Fusion and pathogenic mutations in BCOR and CREBBP: expanding the spectrum of BCOR-altered tumors.
Barresi V; Cardoni A; Miele E; Pedace L; Masotto B; Nardini C; Barresi S; Rossi S
Acta Neuropathol Commun; 2024 Jan; 12(1):8. PubMed ID: 38216991
[TBL] [Abstract][Full Text] [Related]
3. Diffusely infiltrating glioma with CREBBP-BCORL1 fusion showing overexpression of not only BCORL1 but BCOR: A case report.
Yamazaki A; Arai Y; Fukuoka K; Nakano Y; Hama N; Nakata S; Makino K; Kuroda JI; Shinojima N; Mukasa A; Mikami Y; Ichimura K; Shibata T; Yokoo H; Nobusawa S
Brain Tumor Pathol; 2022 Jul; 39(3):171-178. PubMed ID: 35596897
[TBL] [Abstract][Full Text] [Related]
4. Fusions involving BCOR and CREBBP are rare events in infiltrating glioma.
Pisapia DJ; Ohara K; Bareja R; Wilkes DC; Hissong E; Croyle JA; Kim JH; Saab J; MacDonald TY; Beg S; O'Reilly C; Kudman S; Rubin MA; Elemento O; Sboner A; Greenfield J; Mosquera JM
Acta Neuropathol Commun; 2020 Jun; 8(1):80. PubMed ID: 32493417
[TBL] [Abstract][Full Text] [Related]
5. High-grade neuroepithelial tumor with EP300::BCOR fusion and negative BCOR immunohistochemical expression: a case report.
Sugino H; Satomi K; Mori T; Mukai Y; Honda-Kitahara M; Matsushita Y; Ichimura K; Narita Y; Yoshida A
Brain Tumor Pathol; 2023 Apr; 40(2):133-141. PubMed ID: 36811792
[TBL] [Abstract][Full Text] [Related]
6. High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication-a comprehensive clinical, radiographic, pathologic, and genomic analysis.
Ferris SP; Velazquez Vega J; Aboian M; Lee JC; Van Ziffle J; Onodera C; Grenert JP; Saunders T; Chen YY; Banerjee A; Kline CN; Gupta N; Raffel C; Samuel D; Ruiz-Diaz I; Magaki S; Wilson D; Neltner J; Al-Hajri Z; Phillips JJ; Pekmezci M; Bollen AW; Tihan T; Schniederjan M; Cha S; Perry A; Solomon DA
Brain Pathol; 2020 Jan; 30(1):46-62. PubMed ID: 31104347
[TBL] [Abstract][Full Text] [Related]
7. CNS high-grade neuroepithelial tumor with BCOR internal tandem duplication: a comparison with its counterparts in the kidney and soft tissue.
Yoshida Y; Nobusawa S; Nakata S; Nakada M; Arakawa Y; Mineharu Y; Sugita Y; Yoshioka T; Araki A; Sato Y; Takeshima H; Okada M; Nishi A; Yamazaki T; Kohashi K; Oda Y; Hirato J; Yokoo H
Brain Pathol; 2018 Sep; 28(5):710-720. PubMed ID: 29226988
[TBL] [Abstract][Full Text] [Related]
8. Central nervous system high grade neuroepithelial tumor with BCOR immunopositivity: Is there a molecular heterogeneity?
Rao S; Mitra S; Sugur H; Vazhayil V; Rao BRM; Annayappa SK; Nandeesh BN; Yasha TC; Santosh V
Brain Tumor Pathol; 2021 Jan; 38(1):41-49. PubMed ID: 32980923
[TBL] [Abstract][Full Text] [Related]
9. CNS tumor with EP300::BCOR fusion: discussing its prevalence in adult population.
Tauziède-Espariat A; Uro-Coste E; Sievers P; Nicaise Y; Mariet C; Siegfried A; Pierron G; Guillemot D; Benzakoun J; Pallud J; Roques M; Bonneville F; Larrieu-Ciron D; Chaynes P; Saffroy R; Hamelin J; Hasty L; Métais A; Chrétien F; Kool M; Gojo J; Varlet P;
Acta Neuropathol Commun; 2023 Feb; 11(1):26. PubMed ID: 36782314
[TBL] [Abstract][Full Text] [Related]
10. Recurrent EP300-BCOR Fusions in Pediatric Gliomas With Distinct Clinicopathologic Features.
Torre M; Meredith DM; Dubuc A; Solomon DA; Perry A; Vasudevaraja V; Serrano J; Snuderl M; Ligon KL; Alexandrescu S
J Neuropathol Exp Neurol; 2019 Apr; 78(4):305-314. PubMed ID: 30816933
[TBL] [Abstract][Full Text] [Related]
11. The EP300:BCOR fusion extends the genetic alteration spectrum defining the new tumoral entity of "CNS tumors with BCOR internal tandem duplication".
Tauziède-Espariat A; Pierron G; Siegfried A; Guillemot D; Uro-Coste E; Nicaise Y; Castel D; Catalaa I; Larrieu-Ciron D; Chaynes P; de Barros A; Nicolau J; Gareton A; Lechapt E; Chrétien F; Bourdeaut F; Doz F; Bouchoucha Y; Grill J; Beccaria K; Boddaert N; Saffroy R; Pagès M; Varlet P
Acta Neuropathol Commun; 2020 Nov; 8(1):178. PubMed ID: 33138864
[No Abstract] [Full Text] [Related]
12. HGNET-BCOR Tumors of the Cerebellum: Clinicopathologic and Molecular Characterization of 3 Cases.
Appay R; Macagno N; Padovani L; Korshunov A; Kool M; André N; Scavarda D; Pietsch T; Figarella-Branger D
Am J Surg Pathol; 2017 Sep; 41(9):1254-1260. PubMed ID: 28704208
[TBL] [Abstract][Full Text] [Related]
13. Pediatric diffuse glioma with EP300::BCOR fusion manifesting as low-grade epilepsy-associated neuroepithelial tumor: a case presentation.
Nakata S; Arai Y; Fukuoka K; Shirakura T; Yamazaki A; Osawa S; Hama N; Shibata T; Miyagishima T; Horiguchi K; Tosaka M; Yokoo H; Yoshimoto Y; Nobusawa S
Brain Tumor Pathol; 2024 Jan; 41(1):35-39. PubMed ID: 38133797
[No Abstract] [Full Text] [Related]
14. PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum.
Alhalabi KT; Stichel D; Sievers P; Peterziel H; Sommerkamp AC; Sturm D; Wittmann A; Sill M; Jäger N; Beck P; Pajtler KW; Snuderl M; Jour G; Delorenzo M; Martin AM; Levy A; Dalvi N; Hansford JR; Gottardo NG; Uro-Coste E; Maurage CA; Godfraind C; Vandenbos F; Pietsch T; Kramm C; Filippidou M; Kattamis A; Jones C; Øra I; Mikkelsen TS; Zapotocky M; Sumerauer D; Scheie D; McCabe M; Wesseling P; Tops BBJ; Kranendonk MEG; Karajannis MA; Bouvier N; Papaemmanuil E; Dohmen H; Acker T; von Hoff K; Schmid S; Miele E; Filipski K; Kitanovski L; Krskova L; Gojo J; Haberler C; Alvaro F; Ecker J; Selt F; Milde T; Witt O; Oehme I; Kool M; von Deimling A; Korshunov A; Pfister SM; Sahm F; Jones DTW
Acta Neuropathol; 2021 Nov; 142(5):841-857. PubMed ID: 34417833
[TBL] [Abstract][Full Text] [Related]
15. Molecular identification of CNS NB-FOXR2, CNS EFT-CIC, CNS HGNET-MN1 and CNS HGNET-BCOR pediatric brain tumors using tumor-specific signature genes.
Łastowska M; Trubicka J; Sobocińska A; Wojtas B; Niemira M; Szałkowska A; Krętowski A; Karkucińska-Więckowska A; Kaleta M; Ejmont M; Perek-Polnik M; Dembowska-Bagińska B; Grajkowska W; Matyja E
Acta Neuropathol Commun; 2020 Jul; 8(1):105. PubMed ID: 32650833
[TBL] [Abstract][Full Text] [Related]
16. Central nervous system high-grade neuroepithelial tumor with BCOR alteration (CNS HGNET-BCOR)-case-based reviews.
De Lima L; Sürme MB; Gessi M; Mastronuzzi A; Miele E; Tamburrini G; Massimi L
Childs Nerv Syst; 2020 Aug; 36(8):1589-1599. PubMed ID: 32542405
[TBL] [Abstract][Full Text] [Related]
17. Early Wound Site Seeding in a Patient with Central Nervous System High-Grade Neuroepithelial Tumor with BCOR Alteration.
Kirkman MA; Pickles JC; Fairchild AR; Avery A; Pietsch T; Jacques TS; Aquilina K
World Neurosurg; 2018 Aug; 116():279-284. PubMed ID: 29859355
[TBL] [Abstract][Full Text] [Related]
18. Case of the month 1-2019: CNS high-grade neuroepithelial tumor with
Haberler C; Reiniger L; Rajnai H; Kalev O; Gelpi E; Tamesberger M; Pietsch T
Clin Neuropathol; 2019; 38(1):4-7. PubMed ID: 30526817
[TBL] [Abstract][Full Text] [Related]
19. A novel LARGE1-AFF2 fusion expanding the molecular alterations associated with the methylation class of neuroepithelial tumors with PATZ1 fusions.
Tauziède-Espariat A; Chotard G; le Loarer F; Baud J; Azmani R; Dangouloff-Ros V; Boddaert N; Icher-de-Bouyn C; Gimbert E; Hasty L; Métais A; Chrétien F; Varlet P;
Acta Neuropathol Commun; 2022 Feb; 10(1):15. PubMed ID: 35115049
[TBL] [Abstract][Full Text] [Related]
20. Activation of the basal cell carcinoma pathway in a patient with CNS HGNET-BCOR diagnosis: consequences for personalized targeted therapy.
Paret C; Theruvath J; Russo A; Kron B; El Malki K; Lehmann N; Wingerter A; Neu MA; Gerhold-Ay A; Wagner W; Sommer C; Pietsch T; Seidmann L; Faber J
Oncotarget; 2016 Dec; 7(50):83378-83391. PubMed ID: 27825128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
